Occupational exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and risk of infection among healthcare personnel.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
12 2022
Historique:
pubmed: 7 1 2022
medline: 16 12 2022
entrez: 6 1 2022
Statut: ppublish

Résumé

To assess the rate and factors associated with healthcare personnel (HCP) testing positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) after an occupational exposure. Retrospective cohort study. Academic medical center with sites in Minnesota, Wisconsin, Arizona, and Florida. HCP with a high or medium risk occupational exposure to a patient or other HCP with SARS-CoV-2. We reviewed the records of HCP with significant occupational exposures from March 20, 2020, through December 31, 2020. We then performed regression analysis to assess the impact of demographic and occupational variables to assess their impact on the likelihood of testing positive for SARS-CoV-2. In total, 2,253 confirmed occupational exposures occurred during the study period. Employees were the source for 57.1% of exposures. Overall, 101 HCP (4.5%) tested positive in the postexposure period. Of these, 80 had employee sources of exposure and 21 had patient sources of exposure. The postexposure infection rate was 6.2% when employees were the source, compared to 2.2% with patient sources. In a multivariate analysis, occupational exposure from an employee source had a higher risk of testing positive compared to a patient source (odds ratio [OR], 3.22; 95% confidence interval [CI], 1.72-6.04). Sex, age, high-risk exposure, and HCP role were not associated with an increased risk of testing positive. The risk of acquiring coronavirus disease 2019 (COVID-19) following a significant occupational exposure has remained relatively low, even in the prevaccination era. Exposure to an infectious coworker carries a higher risk than exposure to a patient. Continued vigilance and precautions remain necessary in healthcare settings.

Identifiants

pubmed: 34986906
pii: S0899823X2100533X
doi: 10.1017/ice.2021.533
pmc: PMC8814472
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1785-1789

Auteurs

Vishal P Shah (VP)

Division of Preventive, Occupational and Aerospace Medicine, Mayo Clinic, RochesterMinnesota.
Evidence-Based Practice Research Program, Mayo Clinic, RochesterMinnesota.

Laura E Breeher (LE)

Division of Preventive, Occupational and Aerospace Medicine, Mayo Clinic, RochesterMinnesota.
Occupational Health Services, Mayo Clinic, Rochester, Minnesota.

Julie M Alleckson (JM)

Occupational Health Services, Mayo Clinic, Rochester, Minnesota.

David G Rivers (DG)

Occupational Health Services, Mayo Clinic, Rochester, Minnesota.

Zhen Wang (Z)

Evidence-Based Practice Research Program, Mayo Clinic, RochesterMinnesota.

Emily R Stratton (ER)

Division of Preventive, Occupational and Aerospace Medicine, Mayo Clinic, RochesterMinnesota.

Wigdan Farah (W)

Division of Preventive, Occupational and Aerospace Medicine, Mayo Clinic, RochesterMinnesota.

Caitlin M Hainy (CM)

Occupational Health Services, Mayo Clinic, Rochester, Minnesota.

Melanie D Swift (MD)

Division of Preventive, Occupational and Aerospace Medicine, Mayo Clinic, RochesterMinnesota.
Occupational Health Services, Mayo Clinic, Rochester, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH